Home›Search›Cancer Treatment and Research Communications

Cancer Treatment and Research Communications

Elsevier Ltd · United Kingdom · Est. 1953

ISSN2468-2942eISSN2468-2942

SJR Q2✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q2+18

✓ DOAJ Verified+15

Total43

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.971

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.888

Total Works

1,146

Total Citations

9,161

2yr Mean Citedness

1.29

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal publishes research on cancer, including epidemiological studies on cancer incidence and risk factors in specific populations, investigations into the mechanisms of cancer development and progression, and analyses of various treatment modalities and therapeutic targets. It also covers research on diagnostic biomarkers, the impact of external factors like pandemics on cancer screening and care, and the role of the tumor microenvironment and immune responses in cancer. The journal features studies on specific cancer types such as lung, breast, colorectal, prostate, endometrial, and cervical cancers, as well as hematological malignancies.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 50% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1953

Annual Volume~ 131 articles / year

StatusActive (last: 2026)

Total Publications1,146

Publisher OrgElsevier BV

OA Since2019

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~17 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Elsevier Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2468-2942 / 2468-2942

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ2

OncologyQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Research StudiesBreast Cancer Treatment StudiesCancer Genomics and DiagnosticsHER2/EGFR in Cancer ResearchGlobal Cancer Incidence and ScreeningColorectal Cancer Treatments and StudiesBreast Lesions and Carcinomas